[
    [
        {
            "time": "2023-10-18",
            "original_text": "UPDATE 2-Novo Nordisk wins U.S. approval for first-of-its-kind oral diabetes drug",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "U.S. approval",
                    "first-of-its-kind",
                    "oral diabetes drug"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "UPDATE 2-Novo Nordisk wins U.S. approval for first-of-its-kind oral diabetes drug",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "UPDATE 2-European shares log fifth week of gains, Novo Nordisk shines",
            "features": {
                "keywords": [
                    "European shares",
                    "fifth week of gains",
                    "Novo Nordisk"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "stocks"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "UPDATE 2-European shares log fifth week of gains, Novo Nordisk shines",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]